Hospital
Sharkey Issaquena Community Hospital
Sharkey Issaquena Community Hospital was paid $2.67M by Medicaid between Jan 2018 and Oct 2024, across 70 billing codes. Its largest line is G0378, Hospital observation service, per hour — 23% of everything it billed.
33Billing provider infoSHARKEY ISSAQUENA COMMUNITY HOSPITAL
ROLLING FORK, MS 39159
ROLLING FORK, MS 39159
33aNPI1013004795assigned 10/06/2006
33bProvider typeCritical Access Hospital
28Total paid$2.67M
24GClaims79,854
24DCodes billed70
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Critical Access Hospital providers in Mississippi
Rank by total paid#24 of 32
Median peer was paid$3.94M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,751 | $351K | |
| 2019 | 14,518 | $524K | |
| 2020 | 10,070 | $364K | |
| 2021 | 11,247 | $356K | |
| 2022 | 15,232 | $512K | |
| 2023 | 8,966 | $379K | |
| 2024incomplete | 5,070 | $184K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0378 | Hospital observation service, per hour | 23% | 1,272 | 894 | $602K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 16% | 7,612 | 5,412 | $435K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 5,690 | 3,860 | $374K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 12% | 6,031 | 480 | $334K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.5% | 1,445 | 979 | $93K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.4% | 2,800 | 1,999 | $92K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 3.0% | 1,348 | 737 | $80K |
| 71046 | Radiologic examination, chest; 2 views | 2.6% | 3,403 | 2,356 | $69K |
| 87428 | 2.0% | 1,220 | 1,035 | $55K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.0% | 2,678 | 1,666 | $53K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.8% | 1,405 | 160 | $48K |
| 71045 | Radiologic examination, chest; single view | 1.8% | 2,179 | 1,184 | $47K |
58 more codes
| 80053 | Comprehensive metabolic panel | 1.7% | 7,031 | $45K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 8,581 | $43K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 657 | $25K |
| A0425 | Ground mileage, per statute mile | <1% | 932 | $24K |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,351 | $20K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 264 | $20K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 263 | $19K |
| 99284 | Emergency room visit (serious) | <1% | 140 | $19K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 173 | $15K |
| 81007 | <1% | 1,077 | $15K | |
| 84484 | <1% | 2,445 | $15K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 197 | $14K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 126 | $11K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 440 | $10K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 205 | $9K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 74 | $7K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 483 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,118 | $6K |
| 87276 | <1% | 453 | $6K | |
| 74178 | <1% | 18 | $5K | |
| 83880 | <1% | 229 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 109 | $4K |
| 64483 | <1% | 16 | $3K | |
| 86403 | <1% | 396 | $3K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 319 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 64 | $3K |
| 64493 | <1% | 30 | $3K | |
| 87088 | <1% | 860 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 341 | $3K |
| 93271 | <1% | 70 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 87 | $3K |
| 83735 | <1% | 875 | $2K | |
| 74018 | <1% | 74 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 384 | $2K |
| 80061 | Lipid panel | <1% | 344 | $2K |
| 73560 | <1% | 116 | $1K | |
| 62323 | <1% | 26 | $1K | |
| 93041 | <1% | 64 | $1K | |
| 64450 | <1% | 20 | $1K | |
| 81003 | <1% | 691 | $1K | |
| 96376 | <1% | 341 | $1K | |
| 72100 | <1% | 14 | $993.15 | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 172 | $556.48 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 14 | $549.08 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 105 | $543.86 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 94 | $513.72 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 15 | $410.54 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 15 | $410.54 |
| 82728 | <1% | 37 | $329.09 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 16 | $325.60 |
| 81025 | <1% | 40 | $224.75 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 804 | $170.93 |
| 83690 | <1% | 14 | $62.00 | |
| 74019 | <1% | 19 | $59.35 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 115 | $39.60 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 18 | $10.80 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 547 | $7.20 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 248 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKEEVER, STEVEN (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Sharkey Issaquena Community Hospital | Rolling Fork, MS | $31K |
| Sharkey Issaquena Community Hospital | Rolling Fork, MS | $6K |
| Sharkey-Issaquena Community Hospital | Rolling Fork, MS | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.